A Year of Firsts for Alzheimer’s Blood Testing
With the first FDA-cleared test and clinical guidelines debuting since May 2025, labs are evaluating how blood-based biomarkers fit into diagnostic protocols.
Read MorePosted by CLP Edit Staff | Jun 17, 2026 | Dementias & Alzheimer’s |
With the first FDA-cleared test and clinical guidelines debuting since May 2025, labs are evaluating how blood-based biomarkers fit into diagnostic protocols.
Read MorePosted by CLP Edit Staff | Jun 11, 2026 | Compliance, Diagnostic Technologies, Lab Management |
The ADLM honored senator Shelley Moore Capito for advancing pediatric reference intervals, citing her support for related provisions in Senate appropriations bills for FY 2025 and 2026.
Read MorePosted by CLP Edit Staff | Jun 11, 2026 | Compliance |
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
Read MorePosted by CLP Edit Staff | Jun 5, 2026 | Microbiology |
The new capability helps clinicians determine if a patient’s infection will respond to gepotidacin before prescribing the treatment.
Read MorePosted by CLP Edit Staff | Jun 4, 2026 | Accreditation, Compliance, Lab Management |
Laboratories must now pay fees online and access certificates electronically as the program ends paper mailings.
Read More